Abbott Laboratories (LON: 0Q15)

Market Cap	157.59B
Revenue (ttm)	30.75B
Net Income (ttm)	4.29B
Shares Out	n/a
EPS (ttm)	2.45
PE Ratio	36.77
Forward PE	n/a
Dividend	1.72 (1.52%)
Ex-Dividend Date	Jan 15, 2025

Volume	10,150
Open	111.62
Previous Close	107.42
Day's Range	111.22 - 113.28
52-Week Range	104.15 - 121.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 22, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q15

Financial Performance

In 2023, Abbott Laboratories's revenue was $40.11 billion, a decrease of -8.12% compared to the previous year's $43.65 billion. Earnings were $5.70 billion, a decrease of -17.44%.

Financial numbers in USD